{"id":45,"date":"2017-09-19T09:10:17","date_gmt":"2017-09-19T13:10:17","guid":{"rendered":"http:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/?page_id=45"},"modified":"2017-10-25T11:16:29","modified_gmt":"2017-10-25T15:16:29","slug":"speakers","status":"publish","type":"page","link":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/speakers\/","title":{"rendered":"Speakers"},"content":{"rendered":"

\"\"Yogesh Bahl<\/strong><\/span>
\nManaging Director, AlixPartners, LLP<\/p>\n

Mr. Yogesh Bahl has been Managing Director of Financial Advisory Services Group at AlixPartners, LLC since November 2014. Mr. Bahl has more than 20 years of experience leading global investigations, strategy projects and operational-risk initiatives, particularly in the life-sciences industry. He also served as an arbitrator and expert in breach-of-contract, intellectual-property and antitrust disputes. In addition, he is able to leverage his experience in a number of other industries to help life-sciences companies take better advantage of broader leading practices. Prior to joining AlixPartners, he served as a partner in the financial advisory business at Deloitte, for which he led the U.S. life-sciences practice for three years and worked with companies of all sizes. His areas of expertise include global fraud and corruption investigations, third- and fourth-party due diligence, compliance programs, supply-chain risk management and gross-to-net revenue optimization. He has also helped companies manage issues associated with product diversion, counterfeiting and contract compliance. His past work has included: Testifying on damages, antitrust and parallel trade issues in a breach-of-contract action involving the distribution medical devices in the European Union; Serving as arbitrator involving a breach of contract dispute between two global companies; Investigating companies in Europe, Asia and Central America in connection with third-party licensing and distribution agreements; Investigating a joint-development business partner with respect to inaccurate reporting of research-and-development expenses and other suspected breaches of compliance; Creating a pilot analytics program for investigator-initiated trials and speaker programs for a life sciences company; Making recommendations with respect to gross-to-net revenue and related processes, organizational design, systems\/data management, etc. for a pharmaceutical company; and Identifying the use of incorrect rates involving wholesale acquisition costs, chargebacks, rebates and related accounting accruals with respect to a profit-sharing agreement<\/p>\n

\n

\"\"Richard T. Collier<\/span>
\n<\/b>Director, Prothena Corporation plc
\nAdjunct Professor of Law, Temple Law<\/p>\n

Mr. Collier is currently an Adjunct Professor of Law at Temple University Beasley School of Law, where he has taught Drug and Medical Device Law since 2004. He also serves on the Board of Directors of Prothena Corporation, plc, a NASDAQ-listed late-stage clinical biotechnology company, and is a member of both its Nominations and Governance (Chair) and Audit Committees.<\/p>\n

Mr. Collier has over 25 years experience in executive positions in the pharmaceutical and biotechnology industries. Among other positions, he served as the Chief Legal Officer and supervised the compliance function in three publicly-traded global pharmaceutical companies: Rhone-Poulenc Rorer Inc.; Pharmacia & Upjohn Company; and, Pharmacia Corporation. In his last executive role, Mr. Collier served as Executive Vice-President and General Counsel of Elan Corporation, plc., an Irish global biotechnology company. Prior to his corporate career, Mr. Collier practiced law at two leading Philadelphia-based law firms and served with the Federal Trade Commission in Washington, D.C. and the U.S. Department of Justice in Philadelphia. Mr. Collier earned both his BA and JD degrees at Temple University in Philadelphia.<\/p>\n

\n

\"\"James H. Cottrell, Jr. (Chip”)<\/strong><\/span>
\nFormer Chief Ethics Officer and current Senior Advisor – Ethics and Integrity, Deloitte<\/p>\n

Chip Cottrell, a retired Deloitte partner, served in roles of increasing responsibility across Deloitte’s $36 billion, 284 thousand person professional services network – most recently as the Chief Ethics Officer and Chief Sustainability & Corporate Citizenship Leader. He has extensive experience in a broad array of business operations, consulting and accounting, including forensics. Mr. Cottrell is a Certified Public Accountant in the US and China, a UK Chartered Accountant, and a Chartered Global Management Accountant. A recognized and published leader in risk management, corporate governance, ethics and compliance issues, he is a frequent lecturer in academia and corporate board rooms.<\/p>\n

Mr. Cottrell has also served as a co-chair of the UN Global Compact Committee in Anti-Corruption.<\/p>\n

\n

\"\"<\/strong>Peter Driscoll<\/strong><\/span>
\nActing Director, Office of Compliance Inspections and Examinations
\nU.S. Securities and Exchange Commission<\/p>\n

Pete Driscoll was named Acting Director of the U.S. Securities and Exchange Commission\u2019s Office of Compliance Inspections and Examinations (OCIE) in January 2017, after serving as OCIE\u2019s first Chief Risk and Strategy Officer since March 2016. Mr. Driscoll was previously OCIE\u2019s Managing Executive from 2013 through February 2016.<\/p>\n

He joined the Agency in 2001 as a staff attorney in the Division of Enforcement in the Chicago Regional Office and was later a Branch Chief and Assistant Regional Director in OCIE\u2019s Investment Adviser and Investment Company examination program.<\/p>\n

\n

\"\"James A. Fanto<\/span>
\n<\/b>Gerald Baylin Professor of Law
\nBrooklyn Law School<\/p>\n

Professor Fanto is the Gerald Baylin Professor of Law at Brooklyn Law School and Co-Director of the Center for the Study of Business Law & Regulation. He teaches courses on banking, broker-dealer law and regulation, compliance, corporate and securities law, corporate finance and comparative and international corporate law and governance. He writes and speaks on the law relating to banks, broker-dealers, corporate boards and comparative corporate governance, cross-cultural securities disclosure, and merger decision making. Professor Fanto serves as one of the Associate Reporters for the American Law Institute’s project “Principles of the Law, Compliance, Enforcement, and Risk Management for Corporations, Non-Profits, and Other Organizations.”<\/p>\n

\n

\"\"Todd Haugh<\/span>
\n<\/b>Assistant Professor of Business Law and Ethics
\nIndiana University, Kelley School of Business<\/p>\n

Professor Haugh teaches and writes on white collar crime, federal sentencing, and business ethics topics. He is a former Supreme Court Fellow, federal law clerk, and white collar criminal defense attorney. A graduate of the University of Illinois College of Law and Brown University, Professor Haugh\u2019s work has appeared in top law and business journals, including the Northwestern University Law Review, Notre Dame Law Review, Vanderbilt Law Review, and Fordham Law Review. He currently serves as a Jesse Fine Fellow and board member of the Poynter Center for the Study of Ethics and American Institutions.<\/p>\n

\n

\"\"Claire A. Hill<\/span>
\n<\/b>James L. Krusemark Chair in Law
\nUniversity of Minnesota Law School<\/p>\n

Professor Hill teaches corporate law, mergers and acquisitions, contracts, and a seminar in law and economics. She is the founding director of the Law School\u2019s Institute for Law and Rationality, and the associate director of its Institute for Law and Economics. She is also an affiliated faculty member of the University\u2019s Center for Cognitive Sciences and its Center for Political Psychology. At the Law School, she was the 2007-08 Julius E. Davis Professor, 2008-09 Vance K. Opperman Research Scholar, and 2009-11 Solly Robins Distinguished Research Fellow before being appointed the James L. Krusemark Chair in Law in 2011.<\/p>\n

Professor Hill’s research interests include corporate governance, capital structure, structured finance, rating agencies, secured debt, contract theory, law and language, and behavioral economics. She serves as one of the Associate Reporters for the American Law Institute’s project “Principles of the Law, Compliance, Enforcement, and Risk Management for Corporations, Non-Profits, and Other Organizations.”<\/p>\n

\n

\"\"Donald C. Langevoort<\/span>
\n<\/b>Thomas Aquinas Reynolds Professor of Law
\n<\/b>Georgetown University Law Center<\/p>\n

Donald Langevoort is the Thomas Aquinas Reynolds Professor of Law at Georgetown University Law Center.\u00a0Prior to joining the Law Center faculty in 1999, Professor Langevoort was the Lee S. and Charles A. Speir Professor at Vanderbilt University School of Law, where he joined the faculty in 1981. Professor Langevoort teaches contracts, securities regulation, various seminars on corporate and securities issues, and corporations. Professor Langevoort has received the the Frank Flegal Teaching Award at Georgetown and the Paul J. Hartman Award for Excellence in Teaching at Vanderbilt. He has been a visiting professor at Harvard Law School and the University of Michigan Law School and a lecturer at the Washington College of Law, American University. After practicing for two years at Wilmer, Cutler & Pickering in Washington, D.C., he joined the staff of the U.S. Securities & Exchange Commission as Special Counsel in the Office of the General Counsel. Professor Langevoort has testified numerous times before Congressional committees on issues relating to insider trading and securities litigation reform.<\/p>\n

\n

\"\"Jill Fallows Macaluso<\/span>
\n<\/b>Chief Compliance Officer and Vice President
\nNovo Nordisk Inc.<\/p>\n

Jill Fallows Macaluso Esq., RN, is charged with developing, operating, and overseeing an effective healthcare compliance program within the United States for Novo Nordisk. Ms. Fallows Macaluso has been instrumental in driving the evolution of Novo Nordisk\u2019s compliance program to support industry leading business practices.\u00a0As an Executive Team member, she chairs the Executive Compliance Committee and plays an active role ensuring compliance is incorporated into company decision-making processes.\u00a0Prior to joining the Compliance Department, she was Senior Corporate Counsel in the Novo Nordisk’s Legal Department for nine years where she held several key positions. Previously, Ms. Fallows Macaluso was with the General Corporate and Healthcare practice of Day Pitney, LLP.<\/p>\n

\n

\"\"Leonard F. McCarthy<\/span><\/b>
\nFormer Vice President, Institutional Integrity, World Bank Group
\nFounder and President, LF MCCARTHY ASSOCIATES, Inc.<\/p>\n

Leonard McCarthy has been in the business of risk management, litigation, anti-corruption and integrity due diligence at a senior level for more than twenty years. From 2008 until recently, Mr. McCarthy served as the Integrity Vice-President for the World Bank.<\/p>\n

Following the Volcker Panel Report of 2007, then World Bank Group President Robert Zoellick appointed Mr. McCarthy as the World Bank’s Integrity Vice President. As a member of senior management, he reported to the Bank\u2019s President and accounted to its Audit Committee.<\/p>\n

Mr. McCarthy brought about important operational and organizational changes that increased the World Bank\u2019s capacity to mitigate the cost of fraud and corruption. Under his leadership, the World Bank finalized more than 1500 investigations, sanctions, forensic audits, compliance assessments and advisory engagements in infrastructure finance, the energy and natural resource sectors, as well as consulting engineering and manufacturing.<\/p>\n

In 2009, Mr. McCarthy paved the way for the World Bank\u2019s first negotiated settlement, enabling the institution to deal more expediently with companies that admit wrongdoing. Under his management, the World Bank launched the International Corruption Hunters Alliance (ICHA), and also brokered a landmark cross-debarment agreement with other multilateral development banks, resulting in the cross-debarment of 600 entities to date. Mr. McCarthy\u2019s strategic vision led to the establishment of critical new functions at the World Bank including a forensic accounting section, a preventive services unit, and a compliance office.<\/p>\n

Prior to his tenure at World Bank, Mr. McCarthy was appointed by former South African President Nelson Mandela as a director of public prosecutions in 1998, after which he took over as Director for the Office of Serious Economic Offences in June 2000. He then became Head of South Africa\u2019s Directorate of Special Operations (DSO) in 2003, overseeing crime analysis, investigation, prosecution, asset forfeiture and civil litigation. During his tenure, the DSO secured convictions involving corporate wrongdoing, grand corruption, organized crime and urban terrorism.<\/p>\n

Mr. McCarthy chaired the World Economic Forum\u2019s Global Agenda Council on Anti-Corruption & Transparency and participated in the launch of the Volcker Alliance, based in New York.<\/p>\n

He is the founder and president of LF MCCARTHY ASSOCIATES, Inc., an international integrity risk management company based in Washington, D.C. as of July 2017.<\/p>\n

\n

\"\"Paul E. McGreal<\/span>
\n<\/b>Professor of Law
\nCreighton University School of Law<\/p>\n

Professor McGreal joined Creighton University School of Law in 2015 as dean and served in the position through July 31, 2017. He came to Creighton after serving as dean of the University of Dayton School of Law for four years.<\/p>\n

Professor McGreal\u2019s areas of expertise include corporate compliance, business ethics, law and economics, constitutional law, religion and the law, and First Amendment rights. Professor McGreal established the Corporate Compliance Center at the South Texas College of Law, where he taught for 10 years and helped create the college\u2019s joint law-MBA program with Texas A&M University. He also held positions at George Mason University School of Law and Southern Methodist University Dedmam School of Law.<\/p>\n

\n

\"\"John S. Rah<\/span>
\n<\/b>Partner
\n<\/b>DLA Piper<\/p>\n

John Rah advises pharmaceutical and medical device manufacturers, healthcare providers and suppliers and managed healthcare organizations on corporate compliance program development and operations designed to mitigate the risk of fraud and abuse. Mr. Rah counsels clients on investigations and informal inquiries by the U.S. Department of Justice (DOJ) and the U.S. Department of Health and Human Services Office of Inspector General (OIG). His work also includes conducting internal investigations for health care companies involving potential violations of relevant policies and procedures designed to ensure compliance with the anti-kickback and\u00a0 the Food Drug and Cosmetics Act. Mr. Rah also has a deep background in negotiating and implementing Corporate Integrity Agreements, Deferred Prosecution Agreements, and state consent decrees, and regularly interacts with the OIG and other relevant agencies in connection with these integrity agreements.<\/p>\n

\n

\"\"John L. Reed<\/span>
\n<\/b>Partner
\nDLA Piper<\/p>\n

John Reed has more than 20 years of experience successfully litigating cases before the Delaware Court of Chancery and the Delaware Supreme Court, the nation’s preeminent courts for resolving corporate disputes.<\/p>\n

Mr. Reed usually serves as lead counsel and his national practice involves counseling and representing corporations, boards of directors, individual officers and directors, special board committees and large investors with regard to class actions and derivative breach of fiduciary duty claims, corporate control disputes, merger and acquisition litigation, actions involving the interpretation of charter provisions and bylaws, actions by directors\/officers seeking advancement\/indemnification, stockholder appraisal actions, stockholder requests for books and records, internal corporate investigations, litigation arising out of transactions involving subsidiaries, tender offers, asset sales, capital restructurings, stockholder meetings and votes, dissolutions, bankruptcy\/insolvency considerations, corporate reporting and compliance programs and other matters involving corporate law and governance and the interpretation and enforcement of the Delaware General Corporation Law.<\/p>\n

\n

\"\"Myron T. Steele<\/span>
\n<\/b>Partner, Potter Anderson & Corroon LLP
\nFormer Chief Justice of the Supreme Court of Delaware<\/p>\n

Myron Steele is a partner in the firm’s Corporate Group. He is the former Chief Justice of the Supreme Court of Delaware. Previously, he served as a Judge of the Superior Court and a Vice Chancellor of the Delaware Court of Chancery after eighteen years in private litigation practice. He has presided over major corporate litigation and LLC and limited partner governance disputes, and writes frequently on issues of corporate document interpretation and corporate governance.<\/p>\n

Chief Justice Steele has published over 400 opinions resolving disputes among members of limited liability companies, and limited partnerships, and between shareholders and management of both publicly traded and close corporations. He speaks and write frequently on issues of corporate document interpretation and corporate governance.<\/p>\n

Chief Justice Steele served as Adjunct Professor of Law at University of Pennsylvania Law School from 2009\u20132013; University of Virginia Law School 2010\u20132017; and Pepperdine University Law School 2010\u20132014. For the last ten years he served as judicial advisor to the Mergers and Acquisitions Committee of the ABA Business Law Section.<\/p>\n","protected":false},"excerpt":{"rendered":"

Yogesh Bahl Managing Director, AlixPartners, LLP Mr. Yogesh Bahl has been Managing Director of Financial Advisory Services Group at AlixPartners, LLC since November 2014. Mr. Bahl has more than 20 …<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-fullwidth.php","meta":[],"coauthors":[4],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/pages\/45"}],"collection":[{"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/comments?post=45"}],"version-history":[{"count":48,"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/pages\/45\/revisions"}],"predecessor-version":[{"id":223,"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/pages\/45\/revisions\/223"}],"wp:attachment":[{"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/media?parent=45"}],"wp:term":[{"taxonomy":"author","embeddable":true,"href":"https:\/\/www2.law.temple.edu\/events\/tlrsymposium2017\/wp-json\/wp\/v2\/coauthors?post=45"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}